Search Results 1501-1510 of 2835 for site:slotspk17.com

1. A Study Of APG-3288 In Relapsed/Refractory Blood Cancers - Mayo Clinic

   About this study. This is a Phase I, multicenter, open-label, two-stage study of APG-3288 monotherapy, aiming to determine the Maximum Tolerated Dose (MTD) ...

2. A Study Of Rifampicin In Multiple System Atrophy - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

3. Study Of Lumbar Discectomy With Additional Implantation Of An Annular Closure Device In Patients With Large Postsurgical Annular Defects - Mayo Clinic

   About this study. The purpose of this study is to confirm the efficacy of the Barricaid® when used as an adjunct to a primary lumbar limited discectomy, ...

4. A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) And BDX004 Positive Label - Mayo Clinic

   A Phase 2, Multicenter, Study Of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib In Subjects Who Have Previously Untreated Metastatic, ...

5. BBO-11818 In Adult Subjects With KRAS Mutant Cancer - Mayo Clinic

   A first in human study to evaluate the safety and preliminary antitumor activity of BBO-11818, a pan-KRAS inhibitor, in subjects with locally advanced ...

6. MC200404, Safety And Immunogenicity Of PolyPEPI1018 Vaccine In The Treatment Of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   However, TAS-102 is FDA approved for treatment of metastatic colorectal cancer. The FDA has allowed the use of this combination in this research study.

7. Cisplatin With Or Without Veliparib In Treating Patients With Recurrent Or Metastatic Triple-Negative And/or BRCA Mutation-Associated Breast Cancer With Or Without Brain Metastases - Mayo Clinic

   Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from ...

8. Study of RP-6306 With FOLFIRI in Advanced Solid Tumors - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

9. A Study To Determine The Effectiveness And Safety Of Benralizumab For Patients With Severe Nasal Polyposis - Mayo Clinic

   The effect of benralizumab on nasal polyps will be assessed over a 56 weeks of treatment period in patients with severe bilateral nasal polyposis who are still ...

10. A Study Of Ramucirumab Plus Docetaxel In Patients With Urothelial Cancer - Mayo Clinic

    About this study. The main purpose of this study is to evaluate the safety and effectiveness of the study drug ramucirumab in combination with docetaxel in ...